Gluskin Sheff & Assoc Inc. reduced its holdings in shares of VCA Inc. (NASDAQ:WOOF) by 10.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,791 shares of the company’s stock after selling 7,333 shares during the period. Gluskin Sheff & Assoc Inc. owned about 0.08% of VCA worth $5,889,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Meeder Asset Management Inc. bought a new position in VCA during the first quarter valued at approximately $163,000. RBF Capital LLC bought a new position in VCA during the first quarter valued at approximately $201,000. Daiwa Securities Group Inc. bought a new position in VCA during the second quarter valued at approximately $217,000. CNA Financial Corp bought a new position in VCA during the first quarter valued at approximately $238,000. Finally, Fisher Asset Management LLC grew its position in VCA by 8.6% during the second quarter. Fisher Asset Management LLC now owns 3,171 shares of the company’s stock valued at $293,000 after acquiring an additional 250 shares during the last quarter. Institutional investors and hedge funds own 76.52% of the company’s stock.
Shares of VCA Inc. (NASDAQ:WOOF) remained flat at $92.98 during mid-day trading on Wednesday. The company’s stock had a trading volume of 21,697 shares. VCA Inc. has a 12-month low of $59.51 and a 12-month high of $93.00. The firm has a 50-day moving average of $92.74 and a 200-day moving average of $92.16. The firm has a market cap of $7.56 billion, a PE ratio of 34.94 and a beta of 1.01.
VCA (NASDAQ:WOOF) last announced its quarterly earnings data on Wednesday, July 26th. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.94 by $0.02. The company had revenue of $743.13 million for the quarter, compared to the consensus estimate of $735.75 million. VCA had a return on equity of 15.54% and a net margin of 8.00%. During the same quarter in the prior year, the company posted $0.87 EPS. Equities analysts anticipate that VCA Inc. will post $3.23 earnings per share for the current year.
A number of research analysts have commented on the stock. Zacks Investment Research upgraded shares of VCA from a “hold” rating to a “buy” rating and set a $104.00 price target on the stock in a research report on Thursday, September 7th. BidaskClub upgraded shares of VCA from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 29th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $93.00 target price on shares of VCA in a report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. VCA has a consensus rating of “Hold” and a consensus target price of $92.17.
VCA Inc is an animal healthcare company operating in the United States and Canada. The Company operates through five segments: animal hospitals (Animal Hospital), veterinary diagnostic laboratories (Laboratory), veterinary medical technology (Medical Technology), Vetstreet and Camp Bow Wow Franchising, Inc (Camp Bow Wow).
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.